Medtronic Raises FY27 Organic Growth Guidance After Strong Q1

Earnings

โดย The Motley Fool·

Summary · why it matters

Medtronic reported fiscal 2027 first-quarter revenue of $9.8 billion and adjusted EPS of $1.45, both ahead of expectations, and raised its full-year organic revenue growth guidance to 7.25% to 7.75%, a 50 basis point increase from prior guidance. The quarter benefited from an extra selling week, which contributed approximately $570 million or 670 basis points to total organic enterprise revenue growth. Cardiac Rhythm Management delivered 15% global growth, Cranial & Spinal Technologies grew 13%, and Surgical grew 9%. Cardiac Ablation Solutions surged 88% worldwide, surpassing $2 billion in trailing twelve-month revenue. The company also announced strategic investments in Cornerstone Robotics and Pi-Cardia, and expects fiscal 2027 EPS of $5.94 to $6.00.

Medtronic PLC ▲